Leads the Way in Detecting SARS and Deadly Biological Agents
over Severe Acute Respiratory Syndrome (SARS) grows worldwide,
Israeli technology is leading the way in the race to develop a
method of quickly detecting the presence of viruses that cause
such illnesses, ISRAEL21C reported. Integrated Nano-Technologies,
a leading U.S. company, is now using Israeli technology developed
at the Haifa Technion as the backbone of a new DNA based testing
system called BioDetect that will rapidly and accurately test
for the presence of biological pathogens, such as the virus that
causes SARS as well as anthrax, and smallpox.
to a World Health Organization report, a total of 3169 cases of
SARS, with 144 deaths, have been reported to WHO from 21 countries.
New York-based Integrated Nano-Technologies has acquired from
the Technion Research and Development Foundation in Haifa the
right to use three patents developed by its researchers, which
cover the metallization of DNA, and form the basis for the BioDetect
system. Technion’s ground-breaking work in this field has been
recognized in the journals Science and Nature.
to the company, the Israeli technologies, when combined with INT’s
expertise in chip fabrication and molecular biology, will produce
an entirely new and more effective sensor for virus detection.
system will fill a substantial void in current methods of detection,
which are slow, lab-based, and expensive. The system will return
results in less than 30 minutes, and is small enough to be carried
for use outdoors or installed in air circulation systems, according
biological agent detection systems involve sending samples to
laboratories, where they undergo a complex testing process that
can take up to 24 hours to complete," said Michael Connolly,
CEO of Integrated Nano-Technologies.
BioDetect system will generate results in the field substantially
faster and with greater accuracy than any existing system or test."
team included Prof. Uri Sivan, Dr. Yoav Eichen, and technician
Gedalia Ben Yosef. The company paid the Technion $4 million in
cash and will pay royalties on future sales. This is the first
deal of its kind for the Technion in the nanotechnology field.
a Tel-Aviv based company, is also helping in the fight against
SARS, saying last week it would supply electronic monitoring systems
to the Health Ministry of Singapore to monitor the whereabouts
of SARS patients subject to quarantine. Dmatek’s products enable
people to be tracked without interruption while they go about
their daily lives.
New York Israeli Consulate